Acquired-transient factor X deficiency associated with anticardiolipin antibodies in a child with extensive burns

Journal of Burn Care and Research

Volumn 27, Issue 1, 2006, Pages 113-116

  Haberal, Mehmet ^a,b   Basaran, Özgür ^a   Sakallioǧlu, Ayşe E ^a   Kesik, Emine ^a   Alioǧlu, Bülent ^a   Özbek, Namik ^a  

^a BASKENT UNIVERSITY   (Turkey)

^b NONE   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

CARDIOLIPIN ANTIBODY; FRESH FROZEN PLASMA; IMMUNOGLOBULIN; STEROID;

ACQUIRED TRANSIENT FACTOR X DEFICIENCY; AEROBIC BACTERIUM; ANAEROBIC BACTERIUM; ARTICLE; BACTEREMIA; BLOOD CLOTTING; BLOOD CLOTTING FACTOR 10 DEFICIENCY; BRUXISM; BURN; CASE REPORT; DISEASE ASSOCIATION; DISSEMINATED INTRAVASCULAR CLOTTING; EPISTAXIS; FEVER; FOLLOW UP; GINGIVA BLEEDING; HOSPITALIZATION; HUMAN; HYPERTROPHIC SCAR; JAW; LEUKEMOID REACTION; MALE; PLASMA TRANSFUSION; PLASMAPHERESIS; PRESCHOOL CHILD; SCALD; SCAR FORMATION; SEPSIS; TOOTH EXTRACTION; TREATMENT OUTCOME;

ADRENAL CORTEX HORMONES; ANTIBODIES, ANTICARDIOLIPIN; BLOOD TRANSFUSION; BRUXISM; BURNS; DISSEMINATED INTRAVASCULAR COAGULATION; FACTOR X DEFICIENCY; FEVER; HUMANS; IMMUNOGLOBULINS, INTRAVENOUS; INFANT; MALE; PLASMAPHERESIS; SEPSIS; TOOTH EXTRACTION;

EID: 33745656847     PISSN: 1559047X     EISSN: 15590488     Source Type: Journal    
DOI: 10.1097/01.bcr.0000191962.46058.bf     Document Type: Article

References (15)

1. Bauer KA. Rare hereditary coagulation factor abnormalities. In: Nathan DG, Orkin SH, Ginsburg D, Look AT, editors. Nathan and Oski's hematology of the infancy and childhood. 6th ed, vol. 2. Philadelphia: Saunders; 2003. p. 1577-96.
2. Uprichard J, Perry DJ. F-X deficiency. Blood Rev 2002;16:97-110.
3. Choufani EB, Sanchorawala V, Ernst T, et al. Acquired factor X deficiency in patients with amyloid light-chain amyloidosis: incidence, bleeding manifestations, and response to high-dose chemotherapy. Blood 2001;97:1885-7.
4. Currie MS, Stein AM, Rustagi PK, Behrens AN, Logue GL. Transient acquired factor X deficiency associated with pneumonia. N Y State J Med 1984;84:572-3.
5. Gallais V, Bredoux H, le Roux G, Laroche L. Acquired and transient F-X deficiency associated with sodium valproat treatment. Eur J Haematol 1996;57:330.
6. Israels SJ, Leaker ME. Acquired inhibitors to factors V and X after exposure to topical thrombin: interference with monitoring of low molecular weight heparin and warfarin. J Pediatr 1997;131:480-3.
7. Mulhare PE, Tracy PB, Golden EA, Branda RF, Bovill EG. A case of acquired F-X deficiency with in vivo and in vitro evidence of inhibitor activity directed against F-X. Am J Clin Pathol 1991;96:196-200.
8. Matsunaga AT, Shafer FE. An acquired inhibitor to F-X in a pediatric patient with extensive burns. J Pediatr Hematol Oncol 1996;18:223-6.
9. Manabe M, Tsujimaki M, Kakuta S, Nagumo M. Acquired factor X deficiency: an experience with multiple tooth extraction. J Oral Maxillofac Surg 1993;51:922-4.
10. Mackworth-Young CG. Antiphospholipid syndrome: multiple mechanisms. Clin Exp Immunol 2004;136:393-401.
11. Vivaldi P, Rossetti G, Monica G, Finazzi G. Severe bleeding due to acquired hypoprothrombinemia-lupus anticoagulant syndrome. Case report and review of literature. Hematologica 1997;82:345-7.
12. Ashrani AA, Aysola A, Al-Khatib H, Nichols WL, Key NS. Lupus anticoagulant associated with transient factor X deficiency: a report of two patients presenting with major bleeding complications. Br J Haematol 2003;121:639-42.
13. Loizou S, Singh Wypeka W, Asherson RA. Anticardiolipin, anti-β2-glycoprotein I and antiprothrombin antibodies in black South African patients with infectious disease. Ann Rheum Dis 2003;62:1106-11.
14. Henson K, Files JC, Morrison FS. Transient acquired factor X deficiency: Report of the use of activated clotting concentrate to control a life-threatening hemorrhage. Am J Med 1989;87:583-5.
15. Smith SV, Liles DK, White II GC, Brecher ME. Successful treatment of transient acquired F-X deficiency by plasmapheresis with concomitant intravenous immunoglobulin and steroid therapy. Am J Hematol 1998;57:245-52.